REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 209 filers reported holding REATA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $541,156 | +46.7% | 5,952 | -38.7% | 0.04% | +46.2% |
| Q4 2022 | $368,883 | +5.4% | 9,710 | -30.3% | 0.03% | 0.0% |
| Q3 2022 | $350,000 | +108.3% | 13,929 | +1067.6% | 0.03% | +100.0% |
| Q2 2021 | $168,000 | +2300.0% | 1,193 | +1580.3% | 0.01% | +1200.0% |
| Q1 2021 | $7,000 | -82.9% | 71 | -78.7% | 0.00% | -75.0% |
| Q4 2020 | $41,000 | -63.4% | 334 | -71.1% | 0.00% | -69.2% |
| Q3 2020 | $112,000 | +489.5% | 1,157 | +757.0% | 0.01% | +8.3% |
| Q1 2020 | $19,000 | -83.8% | 135 | -96.0% | 0.01% | +50.0% |
| Q2 2018 | $117,000 | – | 3,352 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |